We report a case of tumor lysis syndrome (TLS) in a patient with gallbladder carcinoma. TLS has not been reported in association with this type of tumor. TLS typically occurs in cases of highly proliferative hematological malignancies and small cell carcinoma. Two factors that may have contributed to TLS in this case include multifactorial mild acute renal failure shortly before the administration of chemotherapy and the aggressive morphology of the gallbladder carcinoma, which was a poorly differentiated sarcomatoid variant. This case raises concern for the development of TLS in certain types of patients with solid tumors.
CITATION STYLE
Duff, D. J., Haddadin, S., Freter, C., & Papageorgiou, C. (2013). Gemcitabine and cisplatin-induced tumor lysis syndrome in a patient with gallbladder carcinoma: A case report. Oncology Letters, 5(4), 1237–1239. https://doi.org/10.3892/ol.2013.1189
Mendeley helps you to discover research relevant for your work.